Skip to content

Clinical trials

Phase 4 Ischemic Stroke trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 4 Clear all

147 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20044
20052
20062
20071
20081
20095
20104
20112
20125
20135
20146
20156
20166
20173
20187
20196
20206
20217
202213
202314
202411
202511
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed61
Unknown status39
Recruiting23
Not yet recruiting17
Terminated4
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Xuanwu Hospital, Beijing6
General Hospital of Shenyang Military Region5
Sichuan Provincial People's Hospital4
China Academy of Chinese Medical Sciences3
Dongzhimen Hospital, Beijing3
Kafrelsheikh University3
Second Affiliated Hospital, Zhejiang University, School of Medicine3
Xijing Hospital3
Xinqiao Hospital of Chongqing3
Ain Shams University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke147
Stroke31
Atrial Fibrillation8
Thrombosis7
Brain Ischemia6
Cerebral Infarction4
Hypertension4
Intracranial Arteriosclerosis4
Ischemic Attack, Transient4
Myocardial Infarction4

Trials

Showing 76 to 100 of 147. Each trial links to its page on Pharma Observatory.

47 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.